Sustained antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of emetogenic chemotherapy

201510 citationsJournal Article

Authors

CR rates with APF530 during the acute and delayed phases of CINV in MEC and HEC were maintained over multiple cycles.

Responsible consumption and production

Published in: The Journal of Community and Supportive Oncology

Volume 13, Issue 2, pp. 38-46

Field-Weighted Citation Impact: 2.30